O. Ozensoy, F. Kockar, O. Arslan, S. Isik, C. T. Supuran and M. Lyon, “An Evaluation of Cytosolic Erythrocyte Carbonic Anhydrase and Catalase in Carcinoma Patients: An Elevation of Carbonic Anhydrase Activity,” Clinical Biochemistry, Vol. 39, No. 8, 2006, pp. 804-809. http://dx.doi.org/10.1016/j.clinbiochem.2006.03.001

has been cited by the following article:

• TITLE: Investigating Catalase and Carbonic Anhydrase Enzyme Activities and Levels of Certain Trace Elements and Heavy Metals in Patients with Primary and Metastatic Hepatic Carcinoma

  AUTHORS: Ayse Arslan, Halit Demir, Harun Arslan

  KEYWORDS: Primary and Metastatic Liver Cancer; Catalase; Carbonic Anhydrase; Trace Element; Heavy Metal

  JOURNAL NAME: Journal of Cancer Therapy, Vol.4 No.8, October 29, 2013

  ABSTRACT: Hepatocellular carcinoma (HCC) is among most common terminal cancer types in the world. Primary etiological factors include cirrhosis, hepatitis, aflatoxin and alcohol. The current study was conducted to determine cytosolic erythrocyte carbonic anhydrase and catalase enzyme activities and levels of some trace elements. For this purpose, 40 patients with primary and metastatic hepatic cancer and 29 healthy volunteers enrolled to the study. Catalase and carbonic anhydrase enzyme activities and serum trace element levels were measured in patient and control groups. In the current study, serum copper, magnesium, manganese and zinc levels were lower in the primary and metastatic hepatic cancer group in comparison with the control group (P